NYSE · Healthcare · Medical Devices
Stryker Corporation (SYK)
As of Sep 25, 4:00 PM ET, Stryker (SYK) last traded at $272.36, up 0.97% on the day. Its TickerHum research score is 56/100 (average). It reported revenue of $25.84B for the twelve months ending 2026-06-30, up 8.5% year over year, with a 21.4% operating margin.
Ratings
- Valuation: 71/100 — Strongest input: price / sales (ttm) 4.0x. Weakest: price / earnings (ttm) 28.2x.
- Growth: 63/100 — Strongest input: diluted eps growth (ttm, yoy) +27.8 %. Weakest: revenue growth (ttm, yoy) +8.5 %.
- Profitability: 71/100 — Strongest input: gross margin 65.0 %. Weakest: return on equity 15.5 %.
- Financial health: 57/100 — Strongest input: long-term debt / equity 0.59. Weakest: cash / long-term debt 0.24.
- Momentum: 10/100 — Strongest input: 6-month return -18.1 %. Weakest: 3-month return -18.1 %.
- Attention: 57/100 — Strongest input: headlines in the last 7 days 28. Weakest: volume vs 3-month average 0.8x.
- Risk: 66/100 — Strongest input: annualised volatility (1y) 29.9 %. Weakest: max drawdown (1y) -30.5 %.
- Data confidence: 92/100 — Strongest input: inputs available 100 %. Weakest: quote age (hours) 45 h.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $25.84B | TTM ending 2026-06-30 · 10-Q |
| Revenue growth | 8.5% | TTM ending 2026-06-30 · 10-Q |
| Net income | $3.73B | TTM ending 2026-06-30 · 10-Q |
| Diluted EPS | $9.65 | TTM ending 2026-06-30 · 10-Q |
| Gross margin | 65.0% | TTM ending 2026-06-30 · 10-Q |
| Operating margin | 21.4% | TTM ending 2026-06-30 · 10-Q |
| Net margin | 14.4% | TTM ending 2026-06-30 · 10-Q |
| Free cash flow | $4.7B | TTM ending 2026-06-30 · 10-Q |
| Cash | $3.39B | as of 2026-06-30 · 10-Q |
| Long-term debt | $14.19B | as of 2026-06-30 · 10-Q |
| Debt / equity | 0.59 | as of 2026-06-30 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0000310764).
Compare Stryker with its closest competitors
- Stryker vs Medtronic (SYK vs MDT) — Same industry (Medical Devices); market cap 1.1x; shares: medical devices
- Stryker vs Boston Scientific (SYK vs BSX) — Same industry (Medical Devices); market cap 0.61x; shares: medical devices
- Stryker vs Abbott Laboratories (SYK vs ABT) — Same industry (Medical Devices); market cap 1.7x; shares: medical devices
- Stryker vs Edwards Lifesciences (SYK vs EW) — Same industry (Medical Devices); market cap 0.48x
- Stryker vs Bristol-Myers Squibb (SYK vs BMY) — Same sector (Healthcare), different industry; market cap 1.2x
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.